Method for synthesizing chiral beta-lactam compound
Through the Rh(I) catalyst and rhodium catalytic system, the efficient synthesis of chiral β-lactam is achieved through the activation of asymmetric carbon-carbon bonds, solving the problem of low activation efficiency of cyclopropane compounds in the prior art, and providing high selection and efficient carbon-carbon bond activation pathways.
Patent Information
- Application Number
- CN202411061114.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-05
- Publication Date
- 2024-11-19
AI Technical Summary
The prior art has problems of low efficiency and insufficient diversity in the activation of asymmetric carbon-carbon bonds and the synthesis of chiral β-lactams, especially in the activation and functionalization of cyclopropane compounds, which is difficult to achieve high selectivity. and high efficiency carbon-carbon bond activation.
The Rh(I) catalyst is used to carry out enantioselective asymmetry and carbon-carbon bond activation. Through the paradynamic kinetic resolution of aminocyclopropane, chiral β-lactam is directly generated to avoid the formation of olefin by-products, and to use Rhodium catalysts, ligands, bases and additives react under specific conditions.
Achieve efficient synthesis of chiral β-lactam, providing a new strategy for asymmetric conversion of dialkyl-substituted transition metal intermediates, improving the selectivity and efficiency of carbon-carbon bond activation, and avoiding competition. β-H elimination.
Smart Images

Figure BDA0004977882220000011 
Figure BDA0004977882220000021 
Figure BDA0004977882220000022
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of organic chemistry, and specifically relates to a method for synthesizing chiral beta-lactam compounds. Background Art
[0002] β-lactams have been recognized as a privileged structure in the pharmaceutical industry and have a variety of applications in organic synthesis and the materials industry. After the discovery of penicillin in the 1920s, chiral β-lactams remain one of the most important core structures in modern drug development. Not only are they widely used as antibiotics, but subsequent studies have also revealed other effective activities including anticancer, antifungal, anti-inflammatory, and even antiviral. However, emerging antibiotic resistance has driven the need for innovative synthetic methods that prioritize efficiency and diversity, especially in the generation of easily functionalized chiral β-lactams; the typical structures of important drugs currently known to contain β-lactam structures are as follows:
[0003]
[0004] Transition metal-catalyzed carbon-carbon bond activation reactions are one of the key ideal strategies for atom-economic synthetic chemistry. Asymmetric carbon-carbon bond cleavage / functionalization is very attractive as an emerging field. Currently, most asymmetric carbon-carbon activation systems mainly activate benzocyclobutanones, cyclobutanones, aromatic cyanides or cyclobutanols through oxidative addition or β-elimination processes. Most of them rely on the transformation of TM-C (sp2) intermediates, and the enantioselective transformation of dialkyl-substituted transition metal intermediates C (sp3)-TM-C (sp3) still needs to be explored and is more challenging.
[0005] Compared with cycloolefins, inactive cyclopropanes are easy to obtain carbon-carbon activation substrates. However, since β-hydrides in metal cyclobutanes are generally easy to eliminate and are considered to be an unfavorable process, there are relatively few reports on alkyl cyclopropanes and vinyl cyclopropanes. In addition to the unique η-3-allyl transition metal catalytic system, rapid insertion of CO remains the mainstream way to solve this problem. In addition, since chiral catalysts have difficulty distinguishing between the two proximal carbon-carbon σ bonds in carbon-carbon cleavage, research on asymmetric carbon-carbon activation systems that determine carbon-carbon bond activation by enantiomers is still insufficient, and there are relatively few public literature. In 2023, Shi's group reported the highly enantioselective carbon σ-bond hydroboration of cyclopropane with Rh(I)-catalysis in the absence of CO, and the formation of a dominant carbon-boron bond will inhibit competitive β-H elimination. Therefore, other strategies for the activation of asymmetric carbon-carbon bonds in simple cyclopropanes are still very necessary and need to be studied in depth. Summary of the invention
[0006] In order to overcome the above technical defects, the present invention adopts Rh(I)-catalyzed enantioselective asymmetricization and parallel dynamic kinetic resolution of aminocyclopropane through carbon-carbon bond activation, and directly produces various chiral β-lactams by β-H elimination. In simple aminocyclopropane, the carbon-carbon σ bond enantioselective asymmetricization produces a chiral rhodacyclobutane intermediate, which is then subjected to β-H elimination to achieve hydrogen atom transfer to synthesize chiral β-lactams.
[0007] The method for synthesizing chiral β-lactam compounds of the present invention is generally expressed as follows using the reaction equation:
[0008]
[0009] The steps include:
[0010] A: Using alkynyl amide 1 as raw material, in the presence of rhodium catalyst, ligand, base and additive, the temperature is raised in an organic solvent to obtain chiral β-lactam compound 2; the reaction equation is as follows:
[0011]
[0012] Where: R 1 is selected from benzyl, substituted benzyl, phenylpropyl, C1-C4 alkoxycarbonylmethyl, wherein the substituent in the substituted benzyl is halogen, C1-C4 alkyl, trifluoromethyl; R 2 Selected from phenyl, naphthyl, thienyl, benzothienyl, furyl, benzofuranyl and the corresponding groups of the aforementioned substituents with halogen, nitro, aldehyde, nitrile, phenyl, C1-C4 alkoxy, C1-C4 alkyl, cyclopropyl, C1-C6 alkyl.
[0013] B: Using alkynyl amide trans-3 as raw material, in the presence of rhodium catalyst, ligand, base and additives, the temperature is raised in an organic solvent to obtain chiral β-lactam compounds 4 and 5; the reaction equation is as follows:
[0014]
[0015] Where: R 1 is selected from benzyl, substituted benzyl, phenylpropyl, C1-C4 alkoxycarbonylmethyl, wherein the substituent in the substituted benzyl is halogen, C1-C4 alkyl, trifluoromethyl; R 2 is selected from phenyl, naphthyl, thienyl, benzothienyl, furanyl, benzofuranyl and the corresponding groups of the aforementioned substituents with halogen, nitro, aldehyde, nitrile, phenyl, C1-C4 alkoxy, C1-C4 alkyl, cyclopropyl, C1-C6 alkyl; R 3 The substituents are selected from phenyl, substituted phenyl, substituted benzyl and halogen, nitro, C1-C4 alkyl, C1-C4 alkoxy and trifluoromethyl.
[0016] Furthermore, in the above technical solution, the rhodium catalyst is selected from [Rh(cod)Cl]2 or [RhCl(C2H4)2]2.
[0017] Furthermore, in the above technical solution, the ligand in method A is selected from L4, L5, L7, and L8; and the ligand in method B is selected from L10.
[0018]
[0019] Furthermore, in the above technical solution, the base is selected from sodium tert-butoxide, cesium acetate, sodium acetate or sodium ethoxide.
[0020] Furthermore, in the above technical solution, the additive is selected from copper acetate Cu(OAc)2, zinc acetate Zn(OTf)2, copper trifluoroacetate Cu(OTf)2, triphenylboron BPh3, silver acetate AgOAc, copper octanoate Cu(C8H 15 O2)2, tris(pentafluorophenyl)boron B(C6F5)3, potassium acetate KOAc, sodium acetate NaOAc, magnesium acetate Mg(OAc)2. The additive in method A is preferably copper isooctanoate, and the additive in method B is preferably magnesium acetate.
[0021] Furthermore, in the above technical solution, the molar ratio of the compound 1 / 3, the rhodium catalyst, the ligand, the base and the additive is 1:0.03-0.05:0.06-0.10:040-0.60:0.10-0.20.
[0022] Furthermore, in the above technical solution, the organic solvent is selected from dioxane, tetrahydrofuran, dichloroethane, toluene or ethylene glycol dimethyl ether.
[0023] Furthermore, in the above technical solution, the reaction temperature is selected from 100-150°C; preferably, the reaction temperature is 120°C.
[0024] Furthermore, in the above technical solution, the reaction is carried out under the protection of an inert gas (such as nitrogen or argon).
[0025] Beneficial effects of the present invention:
[0026] A. The present invention uses alkynyl amide as raw material and adopts rhodium catalyst to obtain chiral β-lactam without forming olefin by-product;
[0027] B. The present invention forms a strained four-membered ring rather than a six-membered ring regioselectively; this method provides a new strategy for the asymmetric transformation of dialkyl-substituted transition metal intermediates. Specific embodiments
[0028]
[0029] General Operation A:
[0030] Under nitrogen protection, [Rh(cod)Cl]2 (4.9 mg, 0.01 mmol), L4 (9.3 mg, 0.02 mmol), NaO t Bu (9.6 mg, 0.1 mmol) and 1,4-Dioxane (2.0 mL); the mixture was stirred at room temperature for 40 minutes. Then Cu(C8H 15 O2)2 (7.0 mg, 0.02 mmol) and alkynyl amide 1 (0.2 mmol). Then seal the reaction tube and heat the oil bath to 120°C for 36 hours. After the reaction is completed, cool to room temperature, filter the reaction solution through diatomaceous earth, rinse with ethyl acetate, concentrate the filtrate, and perform column chromatography (PE / EA=3 / 1) to obtain product 2.
[0031] General Operation B:
[0032] Under nitrogen protection, [Rh(cod)Cl]2 (4.9 mg, 0.01 mmol), L8 (9.3 mg, 0.02 mmol), NaO t Bu (9.6 mg, 0.1 mmol) and THF (2.0 mL); the mixture was stirred at room temperature for 40 minutes. Then Cu(C8H 15 O2)2 (7.0 mg, 0.02 mmol) and alkynyl amide 1 (0.2 mmol). Then seal the reaction tube and heat the oil bath to 120°C for 36 hours. After the reaction is completed, cool to room temperature, filter the reaction solution through diatomaceous earth, rinse with ethyl acetate, concentrate the filtrate, and perform column chromatography (PE / EA=3 / 1) to obtain product 2.
[0033]
[0034] Common Operation C:
[0035] Under nitrogen protection, [Rh(cod)Cl]2 (2.5 mg, 0.005 mmol), L10 (4.7 mg, 0.01 mmol), NaOtBu (4.8 mg, 0.05 mmol) and 1,4-Dioxane (1.0 mL) were added in sequence in a 25 mL pressure tube; the mixture was stirred at room temperature for 40 minutes. Then Mg(OAc)2 (2.9 mg, 0.02 mmol) and alkynylamide trans-3 (0.1 mmol) were added. The reaction tube was then sealed and the oil bath was heated to 120°C for 24 hours. After the reaction was completed, the reaction solution was cooled to room temperature, filtered through diatomaceous earth, rinsed with ethyl acetate, the filtrate was concentrated, and the products (S)-4 and (S)-5 were obtained by column chromatography (PE / EA=5 / 1).
[0036] 1.1 Experimental screening of conditions for synthesizing product 2a from compound 1a.[a]
[0037]
[0038] a Reaction conditions: 1a (020mmol), L (002mmol), [Rh(cod)Cl]2 (001mmol), Base (010mmol) in solvent (20mL), 24h, 120℃, isolated yield, argon. b Base (004mmol). c 100℃. d 80℃. e 36h.
[0039] 1.1 Experimental screening of conditions for synthesizing products 4a and 5a from compound trans-form 3a.[a]
[0040]
[0041] [a]Reaction conditions: 3a (01mmol), [Rh(cod)Cl]2 (5mol%), L * (10 mol%), NaO t Bu (50mol%), Lewis acid (20mol%), 120°C in solvent (1.0mL) under argon, 24h[b][Rh(cod)Cl]2 (25mol%) The ee was determined by HPLC on a chiral stationaryphase.
[0042] General operation A, white solid, melting point 55-56°C. 86% yield, 98% ee; Chiralcel AD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =9.4min(major),t R =10.6min(minor).[α] D 27 =23.8(c 1.00,CHCl3). 1 H NMR (400MHz, CDCl3) δ7.99 (d, J=7.2Hz, 2H), 7.44-7.27 (m, 8H), 6.24 (s, 1H), 5.72 (ddd, J=17.0, 10.0, 8.8Hz, 1H), 5.37 (dd ,J=17.0,1.2Hz,1H),5.30(dd,J=10.0,1.2Hz,1H),4.80(d,J=15.0Hz,1H),4.32(d,J=8.8Hz,1H),4.21(d,J=15.0Hz,1H). 13 C NMR(101MHz, CDCl3)δ162.6,140.3,136.1,135.5,134.2,129.9,129.3,129.3,128.9,128.8,128.6,127.8,121.0,61.5,45.0.HRMS(ESI,m / z):calcd for C 19 H 17 NNaO + [M+Na] + :298.1202,found:298.1210.
[0043] General operation A, yellow oily liquid. 64% yield, 98% ee; Chiralcel OD-H column (hexane / isopropanol=90 / 10, flow rate 0.8mL / min): t R =17.9min(major),t R =19.5min(minor).[α] D 27 =46.5(c 0.50,CHCl3). 1H NMR (400MHz, CDCl3) δ8.24-8.12(m,4H),7.39-7.27(m,5H),6.30(s,1H),5.72(ddd,J=17.0,10.0,8.8Hz,1H),5.41(dd, J=17.0,1.2Hz,1H),5.36(dd,J=10.0,1.2Hz,1H),4.80(d,J=15.0Hz,1H),4.36(d,J=8.8Hz,1H),4.22(d,J=15.0Hz,1H). 13 C NMR (101MHz, CDCl3) δ161.6,147.7,145.0,140.2,135.5,134.6,130.6,129.0,128.7,128.1,126.6,124.0,121.8,61.6,45.2.HRMS(ESI,m / z):calcdfor C 19 H 16 N2NaO3 + [M+Na] + :343.1053,found:343.1053.
[0044] General operation A, yellow solid, melting point 85-87°C, 54% yield, 94% ee; Chiralcel OD-H column (hexane / isopropanol=99 / 1, flow rate 0.8mL / min): t R =16.0min(major),t R =17.6min(minor).[α] D 27 =28.6 (c 0.50, CHCl3). 1 H NMR (400MHz, CDCl3) δ8.10(d,J=8.0Hz,2H),7.63(d,J=8.0Hz,2H),7.40-7.25(m,5H),6.27(s,1H),5.72(ddd,J=17.0,10.0,8.8Hz,1H), 5.39(ddd,J=17.0,1.2,0.6Hz,1H), 5.33(dd,J=10.0,1.2Hz,1H), 4.80(d,J=15.0Hz,1H), 4.34(d,J=8.8Hz,1H), 4.22(d,J=15.0Hz,1H). 13C NMR (101MHz, CDCl3) δ162.0,143.1,137.5,135.7,135.0,130.6(q,J=32.2Hz),130.1,12 9.0,128.7,128.0,127.5,125.6(q,J=4.0Hz),124.0(q,J=272.2Hz),121.2,61.5,45.2. 19 F NMR(377MHz, CDCl3)δ-62.76(s,3F).HRMS(ESI,m / z):calcd for C 20 H 16 FWf + [M+Na] + :366.1076,found:366.1075. General operation A, yellow solid, melting point 95-97°C, 70% yield, 96% ee; Chiralcel AD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =26.8min(major),t R =32.8min(minor).[α] D 27 =30.6 (c 0.60, CHCl3). 1 H NMR (400MHz, CDCl3) δ8.09(d,J=8.4Hz,2H),7.65(d,J=8.4Hz,2H),7.40-7.24(m,5H),6.24(s,1H),5.71(ddd,J=17.0,10.0,8.8Hz,1 H),5.40(dd,J=17.0,1.2Hz,1H),5.34(dd,J=10.0,1.2Hz,1H),4.79(d,J=15.0Hz,1H),4.35(d,J=8.8Hz,1H),4.21(d,J=15.0Hz,1H). 13 C NMR (101MHz, CDCl3) δ161.7,144.2,138.3,135.5,134.7,132.5,130.3,129.0 ,128.6,128.0,127.1,121.7,118.9,112.3,61.5,45.2.HRMS(ESI,m / z):calcd for C 20 H 16 N2NaO + [M+Na] +:323.1155,found:323.1155.
[0045] General operation A, reddish brown solid, melting point 47-49°C, 86% yield, 98% ee; Chiralcel AD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =16.8min(major),t R =18.8min(minor).[α] D 27 =43.3(c 0.50,CHCl3). 1 H NMR (400MHz, CDCl3) δ7.97(d,J=8.8Hz,2H),7.38-7.27(m,5H),6.94-6.87(m,2H),6.18(s,1H),5.71(ddd,J=17.0,10.0,8.8Hz,1H),5.34 (dd,J=17.0,1.2Hz,1H),5.28(dd,J=10.0,1.2Hz,1H),4.78(d,J=15.0Hz,1H),4.29(d,J=8.8Hz,1H),4.20(d,J=15.0Hz,1H),3.82(s,3H). 13 C NMR (101MHz, CDCl3) δ162.9,160.4,137.6,136.2,135.7,131.6,128.8,128.5,127.7,127.3,120.6,114.1,61.4,55.4,44.9.HRMS(ESI,m / z):calcd for C 20 H 19 NNaO2 + [M+Na] + :328.1308,found:328.1307.
[0046] General operation A, white solid, melting point 100-102°C, 76% yield, 98% ee; Chiralcel AD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =13.6min(major),t R =15.6min(minor).[α] D 27=28.2(c 0.60,CHCl3). 1 H NMR (400MHz, CDCl3) δ7.77-7.67(m,4H),7.39-7.26(m,5H),6.15(s,1H),5.71(ddd,J=17.0,10.0,8.8Hz,1H),5.36(dd, J=17.0,1.2Hz,1H),5.31(dd,J=10.0,1.2Hz,1H),4.78(d,J=15.0Hz,1H),4.30(d,J=8.8Hz,1H),4.20(d,J=15.0Hz,1H). 13 C NMR(101MHz, CDCl3)δ162.3,141.3,137.9,135.8,135.2,133.7,131.6,128.9,128.6,128.1,127.9,121.2,95.7,61.5,45.1.HRMS(ESI,m / z):calcd for C 19 H 16 INaO + [M+Na] + :424.0169,found:424.0169.
[0047] General operation A, reddish brown solid, melting point 96-98°C, 65% yield, 98% ee; Chiralcel AD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =11.4min(major),t R =12.7min(minor).[α] D 27 =23.0(c 0.60,CHCl3). 1 H NMR (400MHz, CDCl3) δ7.90-7.84(m,2H),7.52-7.46(m,2H),7.39-7.24(m,5H),6.17(s,1H),5.71(ddd,J=17.0,10.0,8.8Hz,1H), 5.37(dd,J=17.0,1.2Hz,1H), 5.31(dd,J=10.0,1.2Hz,1H), 4.78(d,J=15.0Hz,1H), 4.30(d,J=8.8Hz,1H), 4.20(d,J=15.0Hz,1H). 13C NMR(101MHz, CDCl3)δ162.3,141.1,135.9,135.2,133.1,131.9,131.5,128.9,128.6,128.0,127.9,123.6,121.2,61.5,45.1.HRMS(ESI,m / z):calcd for C 19 H 16 NBrNaO + [M+Na] + :376.0308,found:376.0307.
[0048] General operation A, white solid, melting point 78-80°C, 62% yield, 98% ee; Chiralcel AD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =18.9min(major),t R =20.1min(minor).[α] D 27 =44.5(c 0.50,CHCl3). 1 H NMR (400MHz, CDCl3) δ8.12-8.03(m,2H),7.68-7.56(m,4H),7.51-7.43(m,2H),7.41-7.29(m,6H),6.29(s,1H),5.75(ddd,J=17.0,10.0,8. 8Hz,1H),5.38(dd,J=17.0,1.2Hz,1H),5.32(dd,J=10.0,1.2Hz,1H),4.82(d,J=15.0Hz,1H),4.34(d,J=8.8Hz,1H),4.23(d,J=15.0Hz,1H). 13 CNMR (101MHz, CDCl3) δ162.6,141.9,140.6,140.3,136.0,135.5,133.3,130.4,128.9,128 .9,128.8,128.6,127.8,127.7,127.4,127.2,121.0,61.5,45.1.HRMS(ESI,m / z):calcdfor C 25 H 21 NNaO + [M+Na] + :374.1515,found:374.1513.
[0049] General operation A, yellow oily liquid, 57% yield, 98% ee; Chiralcel AD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =8.6min(major),t R =10.7min(minor).[α] D 27 =21.4(c 0.50,CHCl3). 1 H NMR (400MHz, CDCl3) δ8.15-8.12(m,1H),8.04(d,J=7.8Hz,1H),7.46(ddd,J=8.0,2.0,1.0Hz,1H),7.42-7.25(m,6H),6.18(s,1H),5.73(ddd,J=17.0 ,10.0,8.8Hz,1H),5.40(dd,J=17.0,1.2Hz,1H),5.34(dd,J=10.0,1.2Hz, 1H), 4.81 (d, J = 15.0Hz, 1H), 4.34 (d, J = 8.8Hz, 1H), 4.23 (d, J = 15.0Hz, 1H). 13 CNMR (101MHz, CDCl3) δ162.1,141.9,136.2,135.8,135.2,132.7,132.2,130.3,12 8.9,128.7,128.4,127.9,127.6,122.7,121.3,61.5,45.1.HRMS(ESI,m / z):calcd forC 19 H 16 NBrNaO + [M+Na] + :376.0308,found:376.0308.
[0050] General operation A, yellow oily liquid, 84% yield, 98% ee; Chiralcel AD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =8.0min(major),t R =10.7min(minor).[α] D 27 =36.4 (c 0.50, CHCl3). 1H NMR (400MHz, CDCl3) δ7.88-7.78(m,2H),7.41-7.24(m,6H),7.14(d,J=7.4Hz,1H),6.22(s,1H),5.72(ddd,J=17.0,10.0,8.8Hz,1H),5.37 (dd,J=17.0,1.2Hz,1H),5.30(dd,J=10.0,1.2Hz,1H),4.79(d,J=15.0Hz,1H),4.31(d,J=8.8Hz,1H),4.21(d,J=15.0Hz,1H),2.39(s,3H). 13 C NMR (101MHz, CDCl3) δ162.6,140.0,138.3,136.1,135.6,134.1,130.6,130.2,129.5 ,128.9,128.6,128.6,127.8,127.1,120.9,61.5,45.0,21.5.HRMS(ESI,m / z):calcd for C 20 H 19 NNaO + [M+Na] + :312.1359,found:312.1357.
[0051] General operation A, colorless oily liquid, 55% yield, 98% ee; Chiralcel AD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =8.3min(major),t R =9.4min(minor).[α] D 27 =33.6 (c 0.50, CHCl3). 1 H NMR (400MHz, CDCl3) δ8.02(s,1H),7.41-7.27(m,7H),6.92(dt,J=7.0,2.4,2.2Hz,1H),6.25(s,1H),5.74(ddd,J=17.0,10.0,8.8Hz,1H),5. 39(dd,J=17.0,1.2Hz,1H), 5.33(dd,J=10.0,1.2Hz,1H), 4.82(d,J=15.0Hz,1H), 4.34(d,J=8.8Hz,1H), 4.23(d,J=15.0Hz,1H), 3.91(s,3H). 13C NMR (101MHz, CDCl3) δ162.7,160.0,140.4,135.9,135.5,135.4,129.5,129.4,128.9 ,128.6,127.9,122.8,121.0,116.9,113.3,61.5,55.5,45.0.HRMS(ESI,m / z):calcd for C 20 H 19 NNaO2 + [M+Na] + :328.1308,found:328.1308.
[0052] General operation A, reddish brown oily liquid, 62% yield, 96% ee; Chiralcel AD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =7.9min(major),t R =8.7min(minor).[α] D 27 =23.7 (c 0.60, CHCl3). 1 H NMR (400MHz, CDCl3) δ8.59(dd,J=7.8,1.4Hz,1H),7.53-7.25(m,8H),6.63(s,1H),5.87(ddd,J=17.2,10.0,8.8Hz,1H),5.50(dd,J= 17.2, 1.2Hz, 1H), 5.43 (dd, J = 10.0, 1.2Hz, 1H), 4.92 (d, J = 15.0Hz, 1H), 4.46 (d, J = 8.8Hz, 1H), 4.33 (d, J = 15.0Hz, 1H), 2.48 (s, 3H). 13 CNMR (101MHz, CDCl3) δ162.7,140.5,136.6,136.1,135.6,132.4,130.3,130.0,129. 5,128.9,128.6,127.8,126.6,126.2,120.9,61.7,45.0,20.0.HRMS(ESI,m / z):calcd for C 20 H 19 NNaO + [M+Na] + :312.1359,found:312.1358.
[0053] General operation A, yellow oily liquid, 80% yield, 90% ee; Chiralcel AD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =18.5min(major),t R =27.3min(minor).[α] D 27 =26.1(c 0.50,CHCl3). 1 H NMR (400MHz, CDCl3) δ8.44 (dd, J=8.8, 1.8Hz, 1H), 8.18 (s, 1H), 7.90-7.79 ( m,3H),7.53-7.43(m,2H),7.40-7.26(m,5H),6.40(s,1H),5.76(ddd,J=17. 0,10.0,8.8Hz,1H),5.40(dd,J=17.0,1.2Hz,1H),5.33(dd,J=10.0,1.2Hz, 1H), 4.83 (d, J = 15.0Hz, 1H), 4.36 (d, J = 8.8Hz, 1H), 4.24 (d, J = 15.0Hz, 1H). 13 C NMR (101MHz, CDCl3) δ162.6,140.6,136.1,135.6,133.7,133.4,132.1,130.1,129.4,128.9,12 8.7,128.6,128.5,127.9,127.8,127.0,126.9,126.4,121.0,61.6,45.1.HRMS(ESI,m / z):calcd for C 23 H 19 NNaO + [M+Na] + :348.1359,found:348.1358.
[0054] General operation A, yellow solid, melting point 80-82°C, 59% yield, 98% ee; Chiralcel MD-H column (hexane / isopropanol=85 / 15, flow rate 0.8mL / min): t R =9.3min(minor),t R =10.0min(major).[α] D 27 =37.2(c 0.50,CHCl3). 1H NMR (400MHz, CDCl3) δ7.91(dd,J=5.0,1.2Hz,1H),7.84(dd,J=3.0,1.2Hz,1H),7.37-7.30(m,3H),7.30-7.26(m,3H),6.29(s,1H),5.71(ddd,J=17.0 ,10.0,8.8Hz,1H),5.34(dd,J=17.0,1.2Hz,1H),5.28(dd,J=10.0,1.2Hz, 1H), 4.78 (d, J = 15.0Hz, 1H), 4.31 (d, J = 8.8Hz, 1H), 4.19 (d, J = 15.0Hz, 1H). 13 C NMR(101MHz, CDCl3)δ162.8,138.7,136.4,136.1,135.5,129.2,128.9,128.6,128.0,127.8,126.1,121.8,120.8,61.5,45.0.HRMS(ESI,m / z):calcd for C 17 H 15 NSNaO + [M+Na] + :304.0767,found:304.0766.
[0055] General operation A, yellow solid, melting point 72-74°C, 47% yield, 99% ee; Chiralcel IH column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =9.8min(major),t R =11.5min(minor).[α] D 27 =30.7 (c 0.50, CHCl3). 1 H NMR (400MHz, CDCl3) δ7.68(d,J=3.8Hz,1H),7.64(dd,J=7.0,1.4Hz,2H),7.40-7.26(m,9H),6.34(s,1H),5.73(ddd,J=17.0,10.0,8.8Hz ,1H),5.36(dd,J=17.0,1.2Hz,1H),5.30(dd,J=10.0,1.2Hz,1H),4.79(d,J=15.0Hz,1H),4.33(d,J=8.8Hz,1H),4.20(d,J=15.0Hz,1H). 13C NMR (101MHz, CDCl3) δ162.5,147.8,137.7,137.0,136.2,135.5,134.2,132.5,129.1,12 9.0,128.8,128.2,127.9,126.2,124.2,121.1,120.1,61.6,45.1.HRMS(ESI,m / z):calcd forC 23 H 19 NNaSO + [M+Na] + :380.1080,found:380.1085.
[0056] General operation A, reddish brown solid, melting point 79-81°C, 40% yield, 97% ee; Chiralcel IH column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =8.2min(major),t R =9.1min(minor).[α] D 27 =40.1(c 0.50,CHCl3). 1 H NMR(400MHz, CDCl3)δ9.04(s,1H),7.88(dd,J=7.6,1.2Hz,1H),7.82(dd,J=7.6,1.4Hz,1H),7.44-7.27(m,7H),6.61(s,1H),5.77(ddd,J=17.0,10.0 ,8.8Hz,1H),5.42(dd,J=17.0,1.2Hz,1H),5.34(dd,J=10.0,1.2Hz,1H),4 .82(d,J=15.0Hz,1H), 4.40(dd,J=8.8,1.0Hz,1H), 4.23(d,J=15.0Hz,1H). 13 C NMR (101MHz, CDCl3) δ162.9,140.1,139.9,138.0,135.9,135.3,130.2,128.9,128.8 ,128.5,127.8,124.4,122.9,121.1,120.8,118.3,61.6,45.0.HRMS(ESI,m / z):calcd for C 21 H 18 NSO + [M+H] +:332.1104,found:332.1109.
[0057] General operation A, reddish brown oily liquid, 98% ee; Chiralcel OD-H column (hexane / isopropanol=85 / 15, flow rate 0.8mL / min): t R =9.3min(major),t R =11.7min(minor).[α] D 27 =26.0(c 0.50,CHCl3). 1 H NMR (400MHz, CDCl3) δ7.79 (s, 1H), 7.61 (d, J = 7.4Hz, 1H), 7.48-7.45 (m, 1H), 7.39-7.28 (m, 7H), 6.32 (s, 1H), 5.74 (ddd, J = 17.0, 10.0, 8.8 Hz,1H),5.39(dd,J=17.0,1.2Hz,1H),5.33(dd,J=10.0,1.2Hz,1H),4.81(d,J=15.0Hz,1H),4.38(d,J=8.8Hz,1H),4.21(d,J=15.0Hz,1H). 13 C NMR (101MHz, CDCl3) δ162.0,155.2,151.6,141.4,135.9,134.9,129.1,129.0,128.7,12 7.9,125.6,123.3,122.0,121.4,115.9,111.4,109.8,61.7,45.1.HRMS(ESI,m / z):calcd for C 21 H 17 NNaO2 + [M+Na] + :338.1151,found:338.1152.
[0058] General operation A, brown solid, melting point 68-70°C, 47% yield, 98% ee; Chiralcel AD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =31.1min(major),t R =34.1min(minor).[α] D 27=38.6 (c 0.50, CHCl3). 1 H NMR (400MHz, CDCl3) δ9.55(s,1H),7.78(s,1H),7.38-7.27(m,6H),6.11(s,1H),5.70(ddd,J=17.0,10.0,8.8Hz,1H),5.34(dd,J=1 7.0,1.2Hz,1H),5.27(dd,J=10.0,1.2Hz,1H),4.75(d,J=15.0Hz,1H),4.30(d,J=8.8Hz,1H),4.18(d,J=15.0Hz,1H),3.96(s,3H). 13 C NMR (101MHz, CDCl3) δ180.1,163.3,136.7,136.2,135.6,134.3,132.3,128.9,12 8.6,127.8,125.0,120.7,120.1,119.8,61.5,45.0,37.0.HRMS(ESI,m / z):calcd for C 19 H 18 N2NaO2 + [M+Na] + :329.1261,found:329.1264.
[0059] General operation A, yellow oily liquid, 71% yield, 98% ee; Chiralcel AD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =13.3min(major),t R =14.3min(minor).[α] D 27 =27.3(c 0.50,CHCl3). 1 H NMR(400MHz, CDCl3) δ7.99(d,J=7.0Hz,2H),7.61(d,J=8.0Hz,2H),7.47-7.30(m,5H),6.27(s,1H),5.72(ddd,J=17.0,1 0.0,8.8Hz,1H),5.39(dd,J=17.0,1.2Hz,1H),5.32(dd,J=10.0,1.2Hz,1H),4.79(d,J=15.0Hz,1H),4.38-4.26(m,2H). 13C NMR (101MHz, CDCl3) δ162.0,143.1,137.5,135.7,135.0,130.7(q,J=32.2Hz),130.1,12 9.0,128.7,128.0,127.5,125.7(q,J=3.8Hz),124.2(q,J=272.2Hz),121.5,61.5,45.2. 19 F NMR(377MHz, CDCl3)δ-62.55(s,3F).HRMS(ESI,m / z):calcd for C 20 H 16 FWf + [M+Na] + :366.1076,found:366.1077.
[0060] General operation A, yellow solid, melting point 55-57°C, 70% yield, 98% ee; Chiralcel AD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =12.1min(major),t R =14.1min(minor).[α] D 27 =27.6(c 0.50,CHCl3). 1 H NMR(400MHz, CDCl3) δ7.98(d,J=7.0Hz,2H),7.52-7.29(m,5H),7.17(d,J=8.4Hz,2H),6.25(s,1H),5.70(ddd,J=17.0,10.0,8.8Hz,1 H),5.37(dd,J=17.0,1.2Hz,1H),5.31(dd,J=10.0,1.2Hz,1H),4.70(d,J=15.0Hz,1H),4.31(d,J=8.8Hz,1H),4.19(d,J=15.0Hz,1H). 13 CNMR(101MHz, CDCl3)δ162.6,140.0,135.4,135.1,134.1,132.0,130.3,129.9,129.6,129.5,128.8,121.8,121.2,61.6,44.5.HRMS(ESI,m / z):calcd for C 19 H 16 NBrNaO + [M+Na]+ :376.0308,found:376.0308.
[0061] General procedure A, white solid, melting point 61-63°C, 58% yield, 99% ee; Chiralcel AD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =9.4min(major),t R =11.5min(minor).[α] D 27 =35.3 (c 0.50, CHCl3). 1 H NMR (400MHz, CDCl3) δ8.19 (d, J=7.2Hz, 2H), 7.64-7.38 (m, 4H), 7.33-7.27 (m, 3H), 6.43 (s, 1H), 5.92 (ddd, J=17.0, 10.0, 8.8Hz, 1H), 5.57 (dd,J=17.0,1.2Hz,1H),5.50(dd,J=10.0,1.2Hz,1H),4.97(d,J=15.0Hz,1H),4.51(d,J=8.8Hz,1H),4.34(d,J=15.0Hz,1H),2.54(s,3H). 13 C NMR (101MHz, CDCl3) δ162.5,140.4,138.6,135.9,135.5,134.2,129.9,129.3,12 9.2,128.7,128.7,128.6,125.7,120.9,61.4,44.9,21.5.HRMS(ESI,m / z):calcd forC 20 H 19 NNaO + [M+Na] + :312.1359,found:312.1358.
[0062] General operation A, yellow oily liquid, 70% yield, 98% ee; Chiralcel AD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =9.1min(major),t R =10.2min(minor).[α] D 27=28.9 (c 0.50, CHCl3). 1 H NMR (400MHz, CDCl3) δ8.07(d,J=7.2Hz,2H),7.57-7.26(m,8H),6.32(s,1H),5.86(ddd,J=17.0,10.0,8.8Hz,1H),5.55(dd,J=17.0,1.2Hz,1H),5.43 (dd,J=10.0,1.2Hz,1H),4.48(d,J=8.8Hz,1H),3.57(dt,J=13.8,6.8Hz,1 H),3.36(dt,J=13.8,6.8Hz,1H),2.77(t,J=7.8Hz,2H),2.11-1.95(m,2H). 13 C NMR (101MHz, CDCl3) δ162.8,141.3,140.3,136.1,134.3,129.9,129.3,128.8,1 28.7,128.6,128.5,126.2,120.8,62.1,40.8,33.4,29.9.HRMS(ESI,m / z):calcd for C 21 H 21 NNaO + [M+Na] + :326.1515,found:326.1516.
[0063] General operation A, yellow oily liquid, 71% yield, 98% ee; Chiralcel AD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =11.1min(major),t R =12.5min(minor).[α] D 27 =39.4 (c 0.50, CHCl3). 1H NMR (400MHz, CDCl3) δ7.97(d,J=7.0Hz,2H),7.43-7.28(m,3H),6.30(s,1H),5.81(ddd,J=17.0,10.0,8.8Hz,1H),5.48(dd,J=17.0,1.2Hz,1 H),5.37(dd,J=10.0,1.2Hz,1H),4.65(d,J=8.8Hz,1H),4.31(d,J=18.0Hz,1H),4.21(m,2H),3.86(d,J=18.0Hz,1H),1.29(t,J=7.0Hz,3H). 13 C NMR(101MHz, CDCl3)δ168.4,162.7,140.2,135.2,134.1,130.0,129.9,129.5,128.8,121.4,62.6,61.7,42.1,14.3.HRMS(ESI,m / z):calcd for C 16 H 17 NNaO3 + [M+Na] + :294.1101,found:294.1100.
[0064] General operation A, yellow oily liquid, 27% yield, 98% ee; Chiralcel MD-H column (hexane / isopropanol = 90 / 10, flow rate 1 mL / min): t R =14.3min(major),t R =15.1min(minor).[α] D 27 =62.2(c 0.50,CHCl3). 1 H NMR (400MHz, CDCl3) δ = 7.35-7.26 (m, 5H), 5.66 (ddd, J = 17.2, 10.0, 8.8Hz, 1H), 5.29-5.13 (m, 2H), 4.89 (d, J = 10.6Hz, 1H), 4. 74(d,J=15.2Hz,1H),4.19(d,J=8.8Hz,1H),4.11(d,J=15.2Hz,1H),2.36-2.25(m,1H),0.94-0.89(m,2H),0.55-0.46(m,2H). 13C NMR(101MHz, CDCl3)δ164.3,138.2,136.4,135.8,135.0,128.8,128.5,127.7,120.1,61.7,44.6,12.2,8.3.HRMS(ESI,m / z):calcd forC 16 H 17 NNaO + [M+Na] + :262.1202,found:262.1202.
[0065] General operation B, colorless oily liquid, 21% yield, 96% ee; Chiralcel AD-H column (hexane / isopropanol=99 / 1, flow rate 0.8mL / min): t R =20.9min(minor),t R =24.7min(major).[α] D 27 =-30.8 (c 0.50, CHCl3). 1 H NMR (400MHz, CDCl3) δ7.31(m,3H),7.26-7.22(m,2H),5.65(ddd,J=17.0,10.0,8.8Hz,1H),5.51(td,J=7.8,1.2Hz,1H),5.29-5.19(m,2H),4.73 (d,J=15.0Hz,1H),4.20(d,J=8.8Hz,1H),4.11(d,J=15.0Hz,1H),2.48(q,J=7.6Hz,2H),1.48-1.38(m,2H),1.32(m,4H),0.89(t,J=7.6Hz,3H). 13 C NMR (101MHz, CDCl3) δ164.1,140.5,136.3,135.7,130.8,128.8,128.6,127.7,120.2,61.8,44.5,31.4,29.1,28.8,22.6,14.2.HRMS(ESI,m / z):calcd for C 17 H 23 NNaO + [M+Na] + :292.1672,found:292.1678.
[0066] General procedure C, white solid, melting point 96-104°C, 49% yield, 99% ee; Chiralcel IC-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =10.9min(major),t R =12.3min(minor).[α] D 27 =-11.6 (c 0.6, CHCl3). 1 H NMR (400MHz, CDCl3) δ8.06-8.04(m,2H),7.44-7.30(m,13H),6.67(d,J=15.8Hz,1H),6.31(s, 1H), 6.11-6.05 (m, 1H), 4.83 (d, J = 15.0Hz, 1H), 4.53 (d, J = 9.0Hz, 1H), 4.29 (d, J = 15.0Hz, 1H). 13 C NMR (101MHz, CDCl3) δ162.5,140.6,136.1,135.9,135.6,134.2,129.9,129.4,129.3,12 8.8,128.8,128.7,128.6,128.4,127.8,126.7,126.4,61.1,45.0.HRMS(ESI,m / z):calcd forC 25 H 21 ON + [M+Na] + :374.1515,found:374.1508.
[0067] General procedure C, white solid, melting point 101-103°C, 40% yield, 98% ee; Chiralcel OD-H column (hexane / isopropanol=80 / 20, flow rate 0.5mL / min): t R =16.4min(major),t R =17.7min(minor).[α] D 27 =-11.6 (c 0.3, CHCl3). 1H NMR (400MHz, CDCl3) δ7.90(d,J=8.0Hz,2H),7.36-7.29(m,10H),7.20(d,J=8.0Hz,2H),6.63(d,J=15.8Hz,1H),6.26(s ,1H),6.05(dd,J=15.8,9.0Hz,1H),4.80(d,J=15.0Hz,1H),4.49(d,J=9.0Hz,1H),4.26(d,J=15.0Hz,1H),2.36(s,3H). 13 CNMR (101MHz, CDCl3) δ162.8,139.6,139.5,136.2,136.0,135.5,131.6,130.0,129.5,1 29.5,128.9,128.8,128.7,128.4,127.8,126.8,61.2,45.1,21.6.HRMS(ESI,m / z):calcd for C 26 H 23 ON + [M+Na] + :388.1671,found:388.1669.
[0068] General procedure C, yellow solid, melting point 105-108°C, 44% yield, 94% ee; Chiralcel AD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =27.0min(major),t R =32.8min(minor).[α] D 27 =-36.7 (c 0.48, CHCl3). 1 H NMR (400MHz, CDCl3) δ8.10(d,J=8.4Hz,2H),7.65-7.63(m,4H),7.48-7.44(m,2H),7.38-7.30(m,11H),6.67(d,J=1 5.8Hz,1H),6.34(s,1H),6.11-6.05(m,1H),4.84(d,J=15.0Hz,1H),4.54(d,J=9.0Hz,1H),4.30(d,J=15.0Hz,1H). 13C NMR (101MHz, CDCl3) δ162.7,141.9,140.7,140.6,136.1,135.9,135.7,133.3,130.5,129.0,128.9,12 8.9,128.8,128.7,128.5,127.9,127.7,127.4,127.2,126.8,126.5,61.2,45.1.HRMS(ESI,m / z):calcd forC 31 H 25 ON + [M+Na] + :450.1828,found:450.1830.
[0069] General operation C, yellow oily liquid, 40% yield, 94% ee; Chiralcel OD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =11.9min(major),t R =17.9min(minor).[α] D 27 =-11.9 (c 1.3, CHCl3). 1 H NMR (400MHz, CDCl3) δ8.12(d,J=8.2Hz,2H),7.64(d,J=8.2Hz,2H),7.37-7.28(m,10H),6.67(d,J=15.8Hz, 1H), 6.32 (s, 1H), 6.08-6.02 (m, 1H), 4.82 (d, J = 15.0Hz, 1H), 4.54 (d, J = 9.0Hz, 1H), 4.29 (d, J = 15.0Hz, 1H). 19 F NMR(377MHz, CDCl3)δ-62.70(s). 13 C NMR (101MHz, CDCl3) δ162.1, 143.5, 137.5, 136.1, 135.8, 135.8, 130.7 (q, J = 32.4Hz), 130.1, 129.0, 128.9, 128.7 ,128.7,128.0,127.7,126.8,125.9,125.7(q,J=3.7Hz),124.2(q,J=272.1Hz),61.3,45.2.HRMS(ESI,m / z):calcd for C 26 H 20 ONF3Na +[M+Na] + :442.1389,found:442.1383.
[0070] General procedure C, white solid, melting point 113-116°C, 35% yield, 97% ee; Chiralcel AS-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =17.1min(major),t R =19.3min(minor).[α] D 27 =-16.2 (c 0.7, CHCl3). 1 H NMR (400MHz, CDCl3) δ8.11(d,J=8.4Hz,2H),7.65(d,J=8.4Hz,2H),7.37-7.29(m,10H),6.67(d,J=15.8Hz, 1H), 6.29 (s, 1H), 6.06-6.00 (m, 1H), 4.81 (d, J = 15.0Hz, 1H), 4.54 (d, J = 9.0Hz, 1H), 4.28 (d, J = 15.0Hz, 1H). 13 C NMR (101MHz, CDCl3) δ161.8,144.7,138.4,136.3,135.6,135.6,132.5,130.3,129.0,128.9 ,128.7,128.7,128.0,127.3,126.8,125.5,118.9,112.3,61.3,45.3.HRMS(ESI,m / z):calcd for C 26 H 20 ON2Na + [M+Na] + :399.1468,found:399.1463.
[0071] General procedure C, yellow solid, melting point 102-106°C, 35% yield, 96% ee; Chiralcel OD-H column (hexane / isopropanol=85 / 15, flow rate 0.8mL / min): t R =33.2min(minor),t R =37.9min(major).[α] D 27=-12.2 (c 0.3, CHCl3). 1 H NMR (400MHz, CDCl3) δ8.24-8.13(m,4H),7.36-7.26(m,10H),6.68(d,J=15.8Hz,1H),6.35(s, 1H), 6.07-6.01 (m, 1H), 4.82 (d, J = 15.0Hz, 1H), 4.56 (d, J = 9.0Hz, 1H), 4.29 (d, J = 15.0Hz, 1H). 13 CNMR (101MHz, CDCl3) δ161.6,147.7,145.3,140.1,136.4,135.5,135.5,130.5,128.9,128 .8,128.7,128.6,128.0,126.7,126.6,125.3,123.9,61.3,45.2.HRMS(ESI,m / z):calcdfor C 25 H 20 O3N2Na + [M+Na] + :419.1366,found:419.1370.
[0072] General procedure C, white solid, melting point 89-92°C, 38% yield, 95% ee; Chiralcel OD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =15.2min(minor),t R =25.3min(major).[α] D 27 =-12.4 (c 0.1, CHCl3). 1 H NMR (400MHz, CDCl3) δ8.02-7.99(m,2H),7.35-7.30(m,10H),7.09-7.04(m,2H),6.64(d,J=15.8Hz,1H) ,6.24(s,1H),6.07-6.01(m,1H),4.81(d,J=15.0Hz,1H),4.50(d,J=9.0Hz,1H),4.25(d,J=15.0Hz,1H). 19 F NMR(377MHz, CDCl3)δ-110.91–-110.99.(m,1F). 13C NMR (101MHz, CDCl3) δ163.3(d,J=250.2Hz),162.6,140.1(d,J=2.7Hz),136.0,135.9,135.8,132.1,132.0,130.6(d,J=3 .3Hz),129.0,128.9,128.7,128.6,128.2,127.9,126.8,126.4,115.8(d,J=21.6Hz),61.2,45.1.HRMS(ESI,m / z):calcd for C 25 H 20 ONFK + [M+K] + :408.1161,found:408.1158.
[0073] General procedure C, colorless oily liquid, 43% yield, 95% ee; Chiralcel OD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =10.6min(major),t R =14.4min(minor).[α] D 27 =-16.3 (c 0.3, CHCl3). 1 H NMR(400MHz, CDCl3) δ7.95(d,J=8.6Hz,2H),7.35-7.27(m,12H),6.64(d,J=15.8Hz,1H),6.23(s ,1H),6.07-6.01(m,1H),4.80(d,J=15.0Hz,1H),4.50(d,J=9.0Hz,1H),4.26(d,J=15.0Hz,1H). 13 C NMR (101MHz, CDCl3) δ162.4,141.3,136.0,135.9,135.2,132.8,131.3,129.0,129.0 ,128.9,128.7,128.6,128.1,127.9,126.8,126.2,61.2,45.2.HRMS(ESI,m / z):calcd for C 25 H 20 ONClNa + [M+Na] + :408.1126,found:408.1127. General operation C, yellow oily liquid, 32% yield, 96% ee; Chiralcel OD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =12.2min(major),t R =16.9min(minor).[α] D 27 =-24.9 (c 0.23, CHCl3). 1 H NMR (400MHz, CDCl3) δ7.88-7.86(m,2H),7.52-7.48(m,2H),7.36-7.27(m,10H),6.63(d,J=15.8Hz,1H) ,6.21(s,1H),6.06-6.00(m,1H),4.79(d,J=15.0Hz,1H),4.49(d,J=9.0Hz,1H),4.25(d,J=15.0Hz,1H). 13 C NMR (101MHz, CDCl3) δ162.4,141.5,136.0,135.9,135.9,133.2,132.0,131.5,129.0,12 8.9,128.7,128.6,128.2,127.9,126.8,126.2,123.7,61.3,45.2.HRMS(ESI,m / z):calcd for C 25 H 20 ON + [M+Na] + :452.0621,found:452.0616.
[0074] General operation C, colorless oil, 40% yield, 98% ee; Chiralcel AD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =21.9min(major),t R =28.9min(minor).[α] D 27 =-17.1 (c 0.5, CHCl3). 1H NMR(400MHz, CDCl3) δ7.97(d,J=8.8Hz,2H),7.35-7.28(m,10H),6.93-6.90(m,2H),6.63(d,J=15.8Hz,1H),6.2 2(s,1H),6.08-6.02(m,1H),4.80(d,J=15.0Hz,1H),4.48(d,J=9.0Hz,1H),4.26(d,J=15.0Hz,1H),3.83(s,3H). 13 C NMR (101MHz, CDCl3) δ163.0,160.5,138.0,136.3,136.0,135.4,131.7,129.1,128.9,128.8 ,128.7,128.4,127.8,127.3,126.9,126.7,114.2,61.2,55.4,45.1.HRMS(ESI,m / z):calcd for C 26 H 23 O2N + [M+Na] + :404.1621,found:404.1618.
[0075] General procedure C, colorless oily liquid, 27% yield, 97% ee; Chiralcel OD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =7.2min(major),t R =8.4min(minor).[α] D 27 =-14.2 (c 0.2, CHCl3). 1 H NMR (400MHz, CDCl3) δ8.74 (td, J=7.8, 1.6Hz, 1H), 7.37-7.20 (m, 12H), 7.04-6.99 (m, 1H), 6.67-6.6 2(m,2H),6.08-6.01(m,1H),4.81(d,J=15.0Hz,1H),4.53(d,J=9.0Hz,1H),4.27(d,J=15.0Hz,1H). 19 F NMR(377MHz, CDCl3)δ-117.87--117.93.(m,1F). 13C NMR (101MHz, CDCl3) δ162.4,160.6(d,J=251.7Hz),142.0,136.0,135.9,131.4,131.3,131.2,129.0,128.8,128.7,128.5,127.9,1 26.8,126.1,124.7(d,J=3.6Hz),122.0(d,J=10.4Hz),120.4(d,J=6.8Hz),115.3(d,J=22.0Hz),61.3,45.2.HRMS(ESI,m / z):calcd for C 25 H 20 ONF + [M+Na] + :392.1421,found:392.1418.
[0076] General operation C, yellow oily liquid, 31% yield, 94% ee; Chiralcel OD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =20.5min(minor),t R =29.6min(major).[α] D 27 =-52.2 (c 0.5, CHCl3). 1 H NMR (400MHz, CDCl3) δ8.47 (dd, J = 8.6, 1.4Hz, 1H), 8.18 (s, 1H), 7.88-7.82 (m, 3H), 7.51-7.45 (m, 2H), 7.39-7.28 (m, 10H), 6. 67(d,J=15.8Hz,1H),6.45(s,1H),6.12-6.06(m,1H),4.84(d,J=15.0Hz,1H),4.55(d,J=9.0Hz,1H),4.30(d,J=15.0Hz,1H). 13 C NMR (101MHz, CDCl3) δ162.6,140.9,136.1,135.9,135.7,133.7,133.4,132.1,130.2,129.6,128.9,128.8,12 8.7,128.7,128.5,128.5,127.9,127.8,127.0,126.9,126.8,126.5,126.4,61.3,45.1.HRMS(ESI,m / z):calcd forC 29 H23 ON + [M+Na] + :424.1672,found:424.1670.
[0077] General operation C, yellow oily liquid, 27% yield, 92% ee; Chiralcel AD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =16.6min(major),t R =19.2min(minor).[α] D 27 =-15.4 (c 0.5, CHCl3). 1 H NMR (400MHz, CDCl3) δ7.77(d,J=1.8Hz,1H),7.35-7.25(m,11H),6.61(d,J=15.8Hz,1H),6.13(s,1H),6.03(dd,J= 15.8,9.0Hz,1H),4.76(d,J=15.0Hz,1H),4.47(d,J=9.0Hz,1H),4.23(d,J=15.0Hz,1H),3.94(s,3H),3.81(s,3H). 13 C NMR (101MHz, CDCl3) δ163.6,161.7,136.5,136.1,136.1,135.2,132.1,128.9,128.8,128.6,128. 4,127.8,126.9,126.7,123.0,121.1,119.2,118.3,61.2,51.3,45.0,37.3.HRMS(ESI,m / z):calcd for C 26 H 24 O3N2Na + [M+Na] + :435.1679,found:435.1677.
[0078] General operation C, yellow oily liquid, 37% yield, 97% ee; Chiralcel AD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =11.3min(major),t R =12.4min(minor).[α] D27 =-51.2 (c 0.5, CHCl3). 1 H NMR(400MHz, CDCl3)δ9.08(s,1H),7.89-7.79(m,2H),7.41-7.28(m,12H),6.71-6.66(m,2H ),6.13-6.07(m,1H),4.84(d,J=15.0Hz,1H),4.60(d,J=9.0Hz,1H),4.29(d,J=15.0Hz,1H). 13 CNMR(101MHz, CDCl3)δ163.1,140.6,140.0,138.1,136.1,135.9,135.9,130.4,129.1,129.0,128.9 ,128.7,128.6,127.9,126.8,126.4,124.5,123.0,121.0,118.6,61.5,45.1.HRMS(ESI,m / z):calcd forC 27 H 21 ONS + [M+Na] + :430.1236,found:430.1230.
[0079] General procedure C, colorless oily liquid, 30% yield, 97% ee; Chiralcel AD-H column (hexane / isopropanol=90 / 10, flow rate 0.8mL / min): t R =26.7min(major),t R =31.4min(minor).[α] D 27 =13.7(c 0.3,CHCl3). 1 H NMR (400MHz, CDCl3) δ8.00-7.98(m,2H),7.42-7.28(m,8H),6.78(d,J=15.8Hz,1H),6.35(s,1H),6.20-6.14(m,1H ),4.85(d,J=9.0Hz,1H),4.34(d,J=18.0Hz,1H),4.22-4.15(m,2H),3.91(d,J=18.0Hz,1H),1.28(t,J=7.2Hz,3H). 13C NMR (101MHz, CDCl3) δ168.4,162.8,140.6,136.2,135.9,134.1,130.2,130.0,129. 5,128.9,128.8,128.6,126.8,126.0,62.4,61.7,42.1,14.3.HRMS(ESI,m / z):calcd for C 22 H 21 O3N + [M+Na] + :370.1414,found:370.1410.
[0080] General operation C, yellow oily liquid, 28% yield, 98% ee; Chiralcel OD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =13.1min(minor),t R =15.4min(major).[α] D 27 =7.4(c 0.3,CHCl3). 1 H NMR (400MHz, CDCl3) δ7.99(d,J=7.2Hz,2H),7.58(d,J=8.2Hz,2H),7.42-7.28(m,10H),6.65(d,J=15.8Hz, 1H), 6.29 (s, 1H), 6.15-6.09 (m, 1H), 4.77 (d, J = 15.0Hz, 1H), 4.52 (d, J = 9.0Hz, 1H), 4.32 (d, J = 15.0Hz, 1H). 19 F NMR(377MHz, CDCl3)δ-62.61(s). 13 C NMR (101MHz, CDCl3) δ162.5,140.2,139.4,136.0,134.1,133.9,130.4,130.0,129.8,129.6,12 9.0,128.8,128.7,128.0,126.9,125.8(q,J=3.7Hz),122.8,61.0,45.4.HRMS(ESI,m / z):calcd for C 26 H 20 OFN + [M+Na] + :442.1389,found:442.1394. General procedure C, yellow solid, melting point 89-92°C, 22% yield, 98% ee; Chiralcel AD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =15.6min(minor),t R =16.8min(major).[α] D 27 =4.4(c 0.3,CHCl3). 1 H NMR (400MHz, CDCl3) δ8.01-7.99(m,2H),7.41-7.27(m,8H),7.14-7.08(m,2H),7.04-7.01(m,1H),6.53(d,J=15. 8Hz,1H),6.27(s,1H),5.97-5.91(m,1H),4.76(d,J=15.0Hz,1H),4.48(d,J=9.0Hz,1H),4.31(d,J=15.0Hz,1H). 19 F NMR (377MHz, CDCl3) δ-137.32--137.43(m,1F),-137.60--137.71(m,1F). 13 C NMR (101MHz, CDCl3) δ162.5,151.8(dd,J=23.4,18.8Hz),149.2(dd,J=30.6,18.7Hz),140.3,136.1,134.1,133.3,133.2(dd,J=5.9,4.4Hz),130.0 ,129.7,129.5,129.0,128.8,128.7,128.0,123.0(dd,J=6.3,3.5Hz),117.6(d,J=17.5Hz),115.2(d,J=17.5Hz),60.9,45.3.HRMS(ESI,m / z):calcd for C 25 H 19 ONF2Na + [M+Na] + :410.1327,found:410.1323.
[0081] General operation C, yellow oily liquid, 28% yield, 98% ee; Chiralcel OD-H column (hexane / isopropanol=80 / 20, flow rate 0.6mL / min): t R=12.6min(major),t R =14.1min(minor).[α] D 27 =-24.1 (c 0.4, CHCl3). 1 H NMR (400MHz, CDCl3) δ8.00-7.98(m,2H),7.41-7.27(m,8H),7.25-7.10(m,4H),6.61(d,J=15.8Hz,1H),6.28( s,1H),6.07-6.01(m,1H),4.81(d,J=15.0Hz,1H),4.49(d,J=9.0Hz,1H),4.24(d,J=15.0Hz,1H),2.35(s,3H). 13 C NMR (101MHz, CDCl3) δ162.6,140.7,138.5,136.2,135.9,135.8,134.3,130.0,129.5,129.4,129.3 ,128.9,128.8,128.8,128.7,127.9,127.4,126.3,124.0,61.3,45.1,21.5.HRMS(ESI,m / z):calcd for C 26 H 23 ON + [M+Na] + :388.1672,found:388.1676.
[0082] General procedure C, white solid, melting point 89-91°C, 41% yield, 97% ee; Chiralcel OD-H column (hexane / isopropanol=90 / 10, flow rate 0.6mL / min): t R =12.6min(major),t R =13.7min(minor).[α] D 27 =-72.7 (c 0.6, CHCl3). 1 H NMR (400MHz, CDCl3) δ7.94 (d, J = 7.4Hz, 2H), 7.36-7.20 (m, 13H), 6.18 (s, 1H), 5.47 (s,1H),5.36(s,1H),4.88(d,J=15.0Hz,1H),4.76(s,1H),3.95(d,J=15.0Hz,1H). 13C NMR (101MHz, CDCl3) δ163.1,145.1,140.8,138.8,135.6,134.1,129.9,129.3,128.9 ,128.7,128.7,128.7,128.2,127.9,126.9,116.5,61.2,45.2.HRMS(ESI,m / z):calcd for C 25 H 21 ON + [M+Na] + :374.1515,found:374.1514.
[0083] General procedure C, colorless oily liquid, 30% yield, 95% ee; Chiralcel OD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =7.0min(major),t R =7.7min(minor).[α] D 27 =-42.6 (c 0.3, CHCl3). 1 H NMR (400MHz, CDCl3) δ7.85 (d, J = 8.2Hz, 2H), 7.35-7.29 (m, 8H), 7.24-7.17 (m, 4H), 6.18 (s, 1H), 5. 49(s,1H),5.38(s,1H),4.89(d,J=15.0Hz,1H),4.77(s,1H),3.96(d,J=15.0Hz,1H),2.35(s,3H). 13 C NMR (101MHz, CDCl3) δ163.3,145.3,139.7,139.6,138.9,135.7,131.5,130.0,129.5,128.9 ,128.7,128.7,128.7,128.2,127.9,127.0,116.6,61.3,45.2,21.6.HRMS(ESI,m / z):calcd forC 26 H 23 ON + [M+Na] + :388.1672,found:388.1671.
[0084] General procedure C, colorless oily liquid, 35% yield, 96% ee; Chiralcel OD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =10.1min(major),t R =10.9min(minor).[α] D 27 =-72.7 (c 0.6, CHCl3). 1 H NMR (400MHz, CDCl3) δ8.03 (d, J = 8.4Hz, 2H), 7.61-7.59 (m, 4H), 7.45-7.41 (m, 2H), 7.36-7.28 (m, 9H), 7.24-7. 22(m,2H),6.24(s,1H),5.50(s,1H),5.39(s,1H),4.91(d,J=15.0Hz,1H),4.80(s,1H),3.97(d,J=15.0Hz,1H). 13 C NMR (101MHz, CDCl3) δ163.2,145.2,141.9,140.8,140.6,138.8,135.6,133.3,130.5,129.0,128.7 ,128.7,128.3,128.3,127.9,127.7,127.4,127.2,127.0,116.7,61.3,45.3.HRMS(ESI,m / z):calcd for C 31 H 25 ON + [M+Na] + :450.1828,found:450.1827.
[0085] General operation C, yellow oily liquid, 31% yield, 94% ee; Chiralcel OD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =7.2min(major),t R =7.8min(minor).[α] D 27 =-57.8 (c 0.4, CHCl3). 1H NMR (400MHz, CDCl3) δ8.05(d,J=8.2Hz,2H),7.60(d,J=8.2Hz,2H),7.36-7.22(m,10H),6.21( s,1H),5.52(s,1H),5.39(s,1H),4.92(d,J=15.0Hz,1H),4.81(s,1H),3.99(d,J=15.0Hz,1H). 19 F NMR(377MHz, CDCl3)δ-62.74(s). 13 C NMR (101MHz, CDCl3) δ162.6, 144.8, 143.5, 138.6, 137.4, 135.3, 130.7 (q, J = 32.5Hz), 130.1, 129.0, 128.8, 128.8, 128. 41,128.07,126.98,126.87,125.63(q,J=3.7Hz),124.05(q,J=273.1Hz),116.78,61.23,45.32.HRMS(ESI,m / z):calcd forC 26 H 20 OF3 + [M+Na] + :442.1389,found:442.1387.
[0086] General operation C, yellow oily liquid, 25% yield, 95% ee; Chiralcel OD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =14.8min(major),t R =16.3min(minor).[α] D 27 =-57.7 (c 0.4, CHCl3). 1 H NMR (400MHz, CDCl3) δ8.05(d,J=8.4Hz,2H),7.63(d,J=8.4Hz,2H),7.36-7.23(m,10H),6.17( s,1H),5.53(s,1H),5.39(s,1H),4.92(d,J=15.0Hz,1H),4.81(s,1H),4.00(d,J=15.0Hz,1H). 13C NMR (101MHz, CDCl3) δ162.3,144.7,144.5,138.5,138.3,135.1,132.5,130.3,129.1,128.8 ,128.8,128.5,128.1,126.8,126.5,118.9,116.8,112.3,61.2,45.4.HRMS(ESI,m / z):calcd forC 26 H 20 ON2Na + [M+Na] + :399.1468,found:399.1466. General procedure C, yellow solid, melting point 87-89°C, 27% yield, 96% ee; Chiralcel AS-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =13.7min(minor),t R =30.5min(major).[α] D 27 =-77.2 (c 0.4, CHCl3). 1 H NMR (400MHz, CDCl3) δ8.21-8.19(m,2H),8.12-8.10(m,2H),7.38-7.28(m,8H),7.25-7.22(m,2H),6 .22(s,1H),5.55(s,1H),5.40(s,1H),4.94(d,J=15.0Hz,1H),4.83(s,1H),4.02(d,J=15.0Hz,1H). 13 C NMR (101MHz, CDCl3) δ162.2,147.8,145.4,144.5,140.2,138.5,135.1,130.6,130.0,129.1 ,128.9,128.8,128.5,128.2,126.8,126.0,123.9,116.9,61.2,45.4.HRMS(ESI,m / z):calcd for C 25 H 20 O3N2Na + [M+Na] + :419.1366,found:419.1365.
[0087] General procedure C, white solid, melting point 89-91°C, 30% yield, 92% ee; Chiralcel OD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =15.2min(minor),t R =25.3min(major).[α] D 27 =-50.3 (c 0.2, CHCl3). 1 H NMR (400MHz, CDCl3) δ7.98-7.94(m,2H),7.35-7.28(m,8H),7.24-7.22(m,2H),7.05-7.02(m,2H),6 .15(s,1H),5.50(s,1H),5.38(s,1H),4.91(d,J=15.0Hz,1H),4.78(s,1H),3.97(d,J=15.0Hz,1H). 19 FNMR(377MHz, CDCl3)δ-111.00--111.08(m,1F). 13 C NMR (101MHz, CDCl3) δ163.3(d,J=250.2Hz),163.1,145.0,140.3,140.3,138.7,135.5,132.0(d,J=8.5Hz),130.5(d, J=3.5Hz),129.0,128.7,128.3,128.0,127.5,126.9,116.5,115.7(d,J=21.5Hz),61.1,45.2.HRMS(ESI,m / z):calcd for C 25 H 20 ONFK + [M+K] + :408.1161,found:408.1158.
[0088] General operation C, yellow oily liquid, 33% yield, 94% ee; Chiralcel OD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =7.6min(major),t R =8.3min(minor).[α] D 27 =-59.5 (c 0.4, CHCl3). 1H NMR (400MHz, CDCl3) δ7.91-7.89 (d, J=8.6Hz, 2H), 7.34-7.30 (m, 10H), 7.26-7.22 (m, 2H), 6.14 (s,1H),5.51(s,1H),5.38(s,1H),4.90(d,J=15.0Hz,1H),4.78(s,1H),3.98(d,J=15.0Hz,1H). 13 C NMR (101MHz, CDCl3) δ163.0,145.0,141.4,138.7,135.5,135.2,132.7,131.3,129.0 ,128.9,128.8,128.3,128.0,127.4,126.9,116.6,61.2,45.3.HRMS(ESI,m / z):calcd for C 25 H 20 ONClNa + [M+Na] + :408.1126,found:408.1127.
[0089] General procedure C, colorless oily liquid, 21% yield, 94% ee; Chiralcel OD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =7.9min(major),t R =8.6min(minor).[α] D 27 =-58.6 (c 0.3, CHCl3). 1 H NMR (400MHz, CDCl3) δ7.83(d,J=8.6Hz,2H),7.48(d,J=8.6Hz,2H),7.33-7.28(m,8H),7.24-7.22(m,2H ),6.12(s,1H),5.50(s,1H),5.38(s,1H),4.90(d,J=15.0Hz,1H),4.77(s,1H),3.97(d,J=15.0Hz,1H). 13C NMR (101MHz, CDCl3) δ162.9,144.9,141.6,138.7,135.5,133.1,131.9,131.5,129.0 ,128.8,128.4,128.0,127.5,126.9,123.6,116.6,61.2,45.3.HRMS(ESI,m / z):calcd forC 25 H 20 ON + [M+Na] + :452.0620,found:452.0621. General operation C, yellow oily liquid, 25% yield, 97% ee; Chiralcel OD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =9.0min(major),t R =11.3min(minor).[α] D 27 =-63.6 (c 0.5, CHCl3). 1 HNMR (400MHz, CDCl3) δ7.94-7.92(m,2H),7.31-7.22(m,10H),6.91-6.88(m,2H),6.15(s,1H),5. 48(s,1H),5.38(s,1H),4.89(d,J=15.0Hz,1H),4.76(s,1H),3.96(d,J=15.0Hz,1H),3.82(s,3H). 13 C NMR (101MHz, CDCl3) δ163.6,160.5,145.4,138.9,138.2,135.8,131.7,128.9,128.7,128.7 ,128.4,128.2,127.9,127.2,126.9,116.4,114.1,61.2,55.4,45.2.HRMS(ESI,m / z):calcd for C 26 H 23 O2N + [M+Na] + :404.1621,found:404.1622. General procedure C, yellow solid, melting point 52-56°C, 25% yield, 95% ee; Chiralcel AD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =10.2min(minor),t R =13.9min(major).[α] D 27 =-58.6 (c 0.2, CHCl3). 1 H NMR(400MHz, CDCl3)δ8.68(td,J=7.8,1.6Hz,1H),7.33-7.27(m,9H),7.24-7.19(m,3H),7.03-6.98(m,1 H),6.55(s,1H),5.50(s,1H),5.40(s,1H),4.90(d,J=15.0Hz,1H),4.80(s,1H),3.97(d,J=15.0Hz,1H). 19 F NMR(377MHz, CDCl3)δ-117.87--117.94(m,1F). 13 C NMR (101MHz, CDCl3) δ162.9,160.5(d,J=251.6Hz),145.0,142.1,138.7,135.5,131.4,131.2(d,J=8.4Hz),129.0,128.7,128.7,128.3,1 28.0,127.0,124.6(d,J=3.6Hz),122.0(d,J=10.7Hz),119.8(d,J=6.8Hz),117.1,115.3(d,J=21.9Hz).61.5,45.3.HRMS(ESI,m / z):calcd for C 25 H 20 ONF + [M+Na] + :392.1421,found:392.1417.
[0090] General procedure C, white solid, melting point 108-111°C, 24% yield, 96% ee; Chiralcel OD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =9.8min(major),t R =10.6min(minor).[α]D 27 =-94.1 (c 0.3, CHCl3). 1 H NMR(400MHz, CDCl3)δ8.42(dd,J=8.6,1.6Hz,1H),8.13(s,1H),7.86-7.80(m,3H),7.50-7.44(m,2H),7.37-7.30(m,8H) ,7.29-7.26(m,2H),6.37(s,1H),5.53(s,1H),5.42(s,1H),4.94(d,J=15.0Hz,1H),4.84(s,1H),4.01(d,J=15.0Hz,1H). 13 C NMR (101MHz, CDCl3) δ163.2,145.2,141.1,138.8,135.6,133.7,133.4,132.0,130.2,129.0,128.9,128.8,12 8.7,128.7,128.5,128.3,127.9,127.8,127.0,127.0,126.9,126.4,116.6,61.4,45.3.HRMS(ESI,m / z):calcd for C 29 H 23 ON + [M+Na] + :424.1672,found:424.1668.
[0091] General operation C, yellow oily liquid, 16% yield, 93% ee; Chiralcel OD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =10.6min(major),t R =12.5min(minor).[α] D 27 =-54.2 (c 0.4, CHCl3). 1 H NMR (400MHz, CDCl3) δ7.74 (d, J = 1.8Hz, 1H), 7.35-7.27 (m, 8H), 7.25-7.19 (m, 3H), 6.04 (s, 1H), 5.4 6(s,1H),5.35(s,1H),4.86(d,J=15.0Hz,1H),4.75(s,1H),3.97(s,1H),3.93(s,3H),3.80(s,3H). 13C NMR (101MHz, CDCl3) δ164.1,161.7,145.4,138.9,136.3,136.0,132.1,128.9,128.7,128.2,1 27.8,126.9,122.9,120.4,119.2,118.2,116.1,61.2,51.3,45.1,37.3.HRMS(ESI,m / z):calcd forC 26 H 24 O3N2Na + [M+Na] + :435.1679,found:435.1676.
[0092] General operation C, yellow oily liquid, 30% yield, 93% ee; Chiralcel AD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =11.3min(minor),t R =14.4min(major).[α] D 27 =-48.1 (c 0.4, CHCl3). 1 H NMR(400MHz, CDCl3)δ9.03(s,1H),7.88-7.85(m,1H),7.66-7.64(m,1H),7.37-7.30(m,10H),7.26-7.24(m ,2H),6.54(s,1H),5.52(s,1H),5.43(s,1H),4.93(d,J=15.0Hz,1H),4.87(s,1H),4.01(d,J=15.0Hz,1H). 13 C NMR (101MHz, CDCl3) δ163.6,145.2,140.7,140.0,138.8,138.1,135.6,130.2,129.0,128.8,12 8.7,128.4,128.0,127.0,124.5,123.0,120.8,118.0,116.6,61.5,45.3.HRMS(ESI,m / z):calcd for C 27 H 21 ONS + [M+Na] + :430.1236,found:430.1232.
[0093] General operation C, colorless oily liquid, 20% yield, 99% ee; Chiralcel AD-H column (hexane / isopropanol=90 / 10, flow rate 1.0mL / min): t R =12.6min(major),t R =25.1min(minor).[α] D 27 =27.8(c 0.3,CHCl3). 1 H NMR (400MHz, CDCl3) δ7.95-7.93(m,2H),7.40-7.29(m,8H),6.27(s,1H),5.52(s,1H),5.42(s,1H),5 .30(s,1H),4.44(d,J=18.0Hz,1H),4.25-4.14(m,2H),3.61(d,J=18.0Hz,1H),1.28(t,J=7.2Hz,3H). 13 C NMR (101MHz, CDCl3) δ168.4,163.3,144.9,140.8,138.7,134.1,130.1,129.5,129. 5,128.8,128.7,128.4,126.9,116.2,62.2,61.7,42.2,14.3.HRMS(ESI,m / z):calcd for C 22 H 21 O3N + [M+Na] + :370.1414,found:370.1410. General operation C, yellow oily liquid, 20% yield, 91% ee; Chiralcel OD-H column (hexane / isopropanol=80 / 20, flow rate 0.8mL / min): t R =6.6min(major),t R =7.5min(minor).[α] D 27 =-27.2 (c 0.4, CHCl3). 1H NMR (400MHz, CDCl3) δ7.96(d,J=7.2Hz,2H),7.54(d,J=8.2Hz,2H),7.41-7.29(m,8H),7.20-7.18(m,2 H), 6.23 (s, 1H), 5.51 (d, J = 15.6Hz, 2H), 4.84 (d, J = 15.0Hz, 1H), 4.77 (s, 1H), 4.01 (d, J = 15.0Hz, 1H). 19 F NMR(377MHz, CDCl3)δ-62.66(s). 13 C NMR (101MHz, CDCl3) δ163.0,144.5,142.3,140.3,135.4,134.0,130.0,129.6,129.3,129.0 ,128.8,128.7,128.0,127.4,125.6(q,J=3.6Hz),119.0,61.6,45.5.HRMS(ESI,m / z):calcd for C 26 H 20 ONF3Na + [M+Na] + :442.1389,found:442.1395.
[0094] General operation C, yellow oily liquid, 20% yield, 96% ee; Chiralcel OD-H column (hexane / isopropanol=80 / 20, flow rate 0.6mL / min): t R =7.5min(major),t R =8.5min(minor).[α] D 27 =-51.9 (c 0.3, CHCl3). 1 H NMR (400MHz, CDCl3) δ7.97-7.95(m,2H),7.41-7.29(m,6H),7.22-7.20(m,2H),7.10-6.97(m,3H), 6.21(s,1H),5.43(d,J=11.8Hz,2H),4.84(d,J=15.0Hz,1H),4.71(s,1H),4.03(d,J=15.0Hz,1H). 19 F NMR (377MHz, CDCl3) δ-136.92--137.03(m,1F),-138.24--138.36(m,1F). 13C NMR (101MHz, CDCl3) δ163.0, 151.5 (t, J = 12.7Hz), 149.0 (t, J = 12.1Hz), 143.6, 140.2, 135.7 (dd, J = 5.8, 4.0Hz), 135.4, 133.9, 130.0, 129.6, 12 9.2,129.0,128.8,128.7,128.1,123.1(dd,J=6.3,3.6Hz),118.3,117.5(d,J=17.1Hz),116.3(d,J=17.9Hz).61.5,45.5.HRMS(ESI,m / z):calcd forC 25 H 19 ONF2Na + [M+Na] + :410.1327,found:410.1324.
[0095] General operation C, yellow oily liquid, 21% yield, 91% ee; Chiralcel OD-H column (hexane / isopropanol=80 / 20, flow rate 0.6mL / min): t R =9.9min(minor),t R =18.8min(major).[α] D 27 =-61.5 (c 0.4, CHCl3). 1 H NMR (400MHz, CDCl3) δ7.96-7.94(m,2H),7.39-7.29(m,6H),7.24-7.19(m,3H),7.13-7.09(m,3H),6.19(s ,1H),5.48(s,1H),5.37(s,1H),4.91(d,J=15.0Hz,1H),4.78(s,1H),3.99(d,J=15.0Hz,1H),2.32(s,3H). 13 C NMR (101MHz, CDCl3) δ163.2,145.2,141.0,138.9,138.3,135.7,134.3,130.0,129.3,129.0,12 8.9,128.8,128.7,128.6,127.9,127.7,123.9,116.1,61.1,45.2,21.6.HRMS(ESI,m / z):calcd for C 26 H 23 ON + [M+Na]+ :388.1672,found:388.1671.
[0096] The above are only preferred embodiments of the present invention. It should be noted that the above preferred embodiments should not be regarded as limiting the present invention, and the protection scope of the present invention should be based on the scope defined by the claims. For ordinary technicians in this technical field, several improvements and modifications can be made without departing from the spirit and scope of the present invention, and these improvements and modifications should also be regarded as the protection scope of the present invention.
Claims
1. A method for synthesizing chiral β-lactam compounds, characterized in that: The steps include: A: Using alkynyl amide 1 as raw material, in the presence of rhodium catalyst, ligand, base and additive, the temperature is raised in an organic solvent to obtain chiral β-lactam compound 2; the reaction equation is as follows: Where: R 1 is selected from benzyl, substituted benzyl, phenylpropyl, C1-C4 alkoxycarbonylmethyl, wherein the substituent in the substituted benzyl is halogen, C1-C4 alkyl, trifluoromethyl; R 2 Selected from phenyl, naphthyl, thienyl, benzothienyl, furanyl, benzofuranyl and the corresponding groups of the aforementioned substituents with halogen, nitro, aldehyde, nitrile, phenyl, C1-C4 alkoxy, C1-C4 alkyl, cyclopropyl, C1-C6 alkyl; B: Using alkynyl amide trans-3 as raw material, in the presence of rhodium catalyst, ligand, base and additives, the temperature is raised in an organic solvent to obtain chiral β-lactam compounds 4 and 5. The reaction equation is as follows: Where: R 1 is selected from benzyl, substituted benzyl, phenylpropyl, C1-C4 alkoxycarbonylmethyl, wherein the substituent in the substituted benzyl is halogen, C1-C4 alkyl, trifluoromethyl; R 2 is selected from phenyl, naphthyl, thienyl, benzothienyl, furanyl, benzofuranyl and the corresponding groups of the aforementioned substituents with halogen, nitro, aldehyde, nitrile, phenyl, C1-C4 alkoxy, C1-C4 alkyl, cyclopropyl, C1-C6 alkyl; R 3 The substituent is selected from phenyl, substituted phenyl, substituted benzyl and halogen, nitro, C1-C4 alkyl, C1-C4 alkoxy and trifluoromethyl.
2. The method for synthesizing chiral β-lactam compounds according to claim 1, characterized in that: The rhodium catalyst is selected from [Rh(cod)Cl]2 or [RhCl(C2H4)2]2.
3. The method for synthesizing chiral β-lactam compounds according to claim 1, characterized in that: The ligand of method A is selected from L4, L5, L7, and L8; the ligand of method B is selected from L10; and the corresponding structures are as follows:
4. The method for synthesizing chiral β-lactam compounds according to claim 1, characterized in that: The base is selected from sodium tert-butoxide, cesium acetate, sodium acetate or sodium ethoxide.
5. The method for synthesizing chiral β-lactam compounds according to claim 1, characterized in that: The additive is selected from copper acetate, zinc acetate, copper trifluoroacetate, triphenylboron, silver acetate, copper isooctanoate, tri(pentafluorophenyl)boron, potassium acetate, sodium acetate or magnesium acetate.
6. The method for synthesizing chiral β-lactam compounds according to claim 5, characterized in that: The additive in method A is preferably copper isooctanoate, and the additive in method B is preferably magnesium acetate.
7. The method for synthesizing chiral β-lactam compounds according to claim 1, characterized in that: The molar ratio of the compound 1 / 3, rhodium catalyst, ligand, base and additive is 1:0.03-0.05:0.06-0.10:040-0.60:0.10-0.
20.
8. The method for synthesizing chiral β-lactam compounds according to claim 1, characterized in that: The organic solvent is selected from dioxane, tetrahydrofuran, ethylene dichloride, toluene or ethylene glycol dimethyl ether.
9. The method for synthesizing chiral β-lactam compounds according to claim 1, characterized in that: The reaction temperature is selected from 100-150°C.
10. The method for synthesizing chiral β-lactam compounds according to any one of claims 1 to 9, characterized in that: The reaction was carried out under inert gas protection.
